Pharmaceuticals, Biotechnology and Life Sciences
The health system has been a leading contributor to the study since its launch in partnership with National Institutes of…
NEWARK, Calif.–(BUSINESS WIRE)–Aradigm Corporation (OTC PINK: ARDM) (“Aradigm” or the “Company”) announced on April 27, 2020, the Bankruptcy Court entered…
Novocure has posted quarterly net revenues of $101.8 million, representing 39 percent growth versus the first quarter 2019 and 3 percent growth versus the fourth quarter 2019.
– FDA’s Physical-Chemical Identifier Guidance and 1-1 Interaction Will Guide Use of SigNature® Platform in Counterfeit-Risk Mitigation, Brand/IP Protection and…
DUBLIN–(BUSINESS WIRE)–The “Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth” report has…
PEACHTREE CORNERS, Ga.–(BUSINESS WIRE)–#FDA–Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless cervical cancer detection test…
Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, announced today that they will be offering Surface Plasmon Resonance (SPR) technical support to all researchers – at no cost – during COVID-19.
Athara Biotherapeutics has appointed biotech and finance industry veteran Ron Renaud as a director and non-executive chair of the board of directors.
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney disease, today announced the appointment of Kyle Kuvalanka as Chief Financial and Operating Officer and the promotion of Lori Rudolph-Owen, Ph.D., from Senior Vice President, R&D Strategy and Operations to Chief Development Officer, effective immediately.
59% Complete Response in patients with low-grade upper tract urothelial cancer Kaplan-Meier analysis, based on interim data, estimated 12-month durability…